Eli Lilly, the maker of Zepbound and Mounjaro, said its experimental GLP-1 pill successfully helped adults with obesity lose weight in a Phase 3 trial, as the company moves closer
Eli Lilly, the maker of Zepbound and Mounjaro, said its experimental GLP-1 pill successfully helped adults with obesity lose weight in a Phase 3 trial, as the company moves closer
Health and Human Services Secretary Robert F. Kennedy Jr. has asked Food and Drug Administration Commissioner Marty Makary “to review the latest data on mifepristone,” raising questions about the drug
Philippa Roxby Well being reporter BBC Linda says the drug has given her additional years of life Linda Kelly, 67, has superior breast most cancers which has unfold to her